Lyophilization is a process that removes moisture from a product while preserving its original chemical properties. Also known as freeze drying, this process is used in the production of many products, such as pharmaceuticals, biologics, food additives, and nutraceuticals. Lyophilization helps to reduce spoilage and extend the shelf life of a product, making it more stable and easier to transport.Pharmaceutical companies use lyophilization to make lyophilized injections, eye drops, other sensitive drugs, and parenteral dosage forms that cannot be manufactured through traditional methods. In the biopharmaceutical industry, lyophilization is used to preserve proteins and peptides for long-term storage, giving unstable biologics the shelf life and stability for more widespread distribution and use.
Lyophilization contract manufacturing services are beneficial for pharmaceutical and biopharmaceutical companies who lack the necessary resources and expertise to produce their own lyophilized products. Lyophilization is a meticulous process, but with experienced professionals to help guide the way, an effective lyophilized drug can be produced in a short amount of time.
The global Lyophilization Contract Manufacturing Services (CDMO) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Lyophilization Contract Manufacturing Services (CDMO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lyophilization Contract Manufacturing Services (CDMO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Lyophilization Contract Manufacturing Services (CDMO) in Pharmaceutical Company is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Lyophilization Contract Manufacturing Services (CDMO) include Thermo Fisher Scientific Inc., Ascendia Pharmaceuticals, PCI Pharma Services, Ellab, Lyophilization Technology,Inc., Lundbeck, LSNE Con鈥嬧�媡ract Manufacturing, Pfizer and Jubilant Pharmova, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lyophilization Contract Manufacturing Services (CDMO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lyophilization Contract Manufacturing Services (CDMO).
Report Scope
The Lyophilization Contract Manufacturing Services (CDMO) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lyophilization Contract Manufacturing Services (CDMO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lyophilization Contract Manufacturing Services (CDMO) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Thermo Fisher Scientific Inc.
Ascendia Pharmaceuticals
PCI Pharma Services
Ellab
Lyophilization Technology,Inc.
Lundbeck
LSNE Con鈥嬧�媡ract Manufacturing
Pfizer
Jubilant Pharmova
CARBOGEN AMCIS
Lubrizol Life Science
Recipharm AB
Berkshire Sterile Manufacturing
AbbVie
Zenvision Pharma LLP
Eurofins
COC Farmaceutici
Leadgene Biomedical,Inc.
Liof Pharma
Argonaut Manufacturing Services
Societal CDMO
PharmTech
Oakwood Labs
IDT Biologika
EMCM
Segment by Type
Formulation&Process Development
Lyophilization
Clinical Supply Manufacturing
Commercial Manufacturing
Storage&Distribution
Analytical Services
Segment by Application
Pharmaceutical Company
Biotechnology Company
Generic Company
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lyophilization Contract Manufacturing Services (CDMO) companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Formulation&Process Development
1.2.3 Lyophilization
1.2.4 Clinical Supply Manufacturing
1.2.5 Commercial Manufacturing
1.2.6 Storage&Distribution
1.2.7 Analytical Services
1.3 麻豆原创 by Application
1.3.1 Global Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Generic Company
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Perspective (2019-2030)
2.2 Lyophilization Contract Manufacturing Services (CDMO) Growth Trends by Region
2.2.1 Global Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Lyophilization Contract Manufacturing Services (CDMO) Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Lyophilization Contract Manufacturing Services (CDMO) Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Dynamics
2.3.1 Lyophilization Contract Manufacturing Services (CDMO) Industry Trends
2.3.2 Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Drivers
2.3.3 Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Challenges
2.3.4 Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lyophilization Contract Manufacturing Services (CDMO) Players by Revenue
3.1.1 Global Top Lyophilization Contract Manufacturing Services (CDMO) Players by Revenue (2019-2024)
3.1.2 Global Lyophilization Contract Manufacturing Services (CDMO) Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lyophilization Contract Manufacturing Services (CDMO) Revenue
3.4 Global Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Concentration Ratio
3.4.1 Global Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lyophilization Contract Manufacturing Services (CDMO) Revenue in 2023
3.5 Lyophilization Contract Manufacturing Services (CDMO) Key Players Head office and Area Served
3.6 Key Players Lyophilization Contract Manufacturing Services (CDMO) Product Solution and Service
3.7 Date of Enter into Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Lyophilization Contract Manufacturing Services (CDMO) Breakdown Data by Type
4.1 Global Lyophilization Contract Manufacturing Services (CDMO) Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Lyophilization Contract Manufacturing Services (CDMO) Forecasted 麻豆原创 Size by Type (2025-2030)
5 Lyophilization Contract Manufacturing Services (CDMO) Breakdown Data by Application
5.1 Global Lyophilization Contract Manufacturing Services (CDMO) Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Lyophilization Contract Manufacturing Services (CDMO) Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Size (2019-2030)
6.2 North America Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Size by Country (2019-2024)
6.4 North America Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Size (2019-2030)
7.2 Europe Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Size by Country (2019-2024)
7.4 Europe Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Size (2019-2030)
9.2 Latin America Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Lyophilization Contract Manufacturing Services (CDMO) 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Detail
11.1.2 Thermo Fisher Scientific Inc. Business Overview
11.1.3 Thermo Fisher Scientific Inc. Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.1.4 Thermo Fisher Scientific Inc. Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.1.5 Thermo Fisher Scientific Inc. Recent Development
11.2 Ascendia Pharmaceuticals
11.2.1 Ascendia Pharmaceuticals Company Detail
11.2.2 Ascendia Pharmaceuticals Business Overview
11.2.3 Ascendia Pharmaceuticals Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.2.4 Ascendia Pharmaceuticals Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.2.5 Ascendia Pharmaceuticals Recent Development
11.3 PCI Pharma Services
11.3.1 PCI Pharma Services Company Detail
11.3.2 PCI Pharma Services Business Overview
11.3.3 PCI Pharma Services Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.3.4 PCI Pharma Services Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.3.5 PCI Pharma Services Recent Development
11.4 Ellab
11.4.1 Ellab Company Detail
11.4.2 Ellab Business Overview
11.4.3 Ellab Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.4.4 Ellab Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.4.5 Ellab Recent Development
11.5 Lyophilization Technology,Inc.
11.5.1 Lyophilization Technology,Inc. Company Detail
11.5.2 Lyophilization Technology,Inc. Business Overview
11.5.3 Lyophilization Technology,Inc. Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.5.4 Lyophilization Technology,Inc. Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.5.5 Lyophilization Technology,Inc. Recent Development
11.6 Lundbeck
11.6.1 Lundbeck Company Detail
11.6.2 Lundbeck Business Overview
11.6.3 Lundbeck Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.6.4 Lundbeck Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.6.5 Lundbeck Recent Development
11.7 LSNE Con鈥嬧�媡ract Manufacturing
11.7.1 LSNE Con鈥嬧�媡ract Manufacturing Company Detail
11.7.2 LSNE Con鈥嬧�媡ract Manufacturing Business Overview
11.7.3 LSNE Con鈥嬧�媡ract Manufacturing Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.7.4 LSNE Con鈥嬧�媡ract Manufacturing Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.7.5 LSNE Con鈥嬧�媡ract Manufacturing Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.8.4 Pfizer Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.8.5 Pfizer Recent Development
11.9 Jubilant Pharmova
11.9.1 Jubilant Pharmova Company Detail
11.9.2 Jubilant Pharmova Business Overview
11.9.3 Jubilant Pharmova Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.9.4 Jubilant Pharmova Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.9.5 Jubilant Pharmova Recent Development
11.10 CARBOGEN AMCIS
11.10.1 CARBOGEN AMCIS Company Detail
11.10.2 CARBOGEN AMCIS Business Overview
11.10.3 CARBOGEN AMCIS Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.10.4 CARBOGEN AMCIS Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.10.5 CARBOGEN AMCIS Recent Development
11.11 Lubrizol Life Science
11.11.1 Lubrizol Life Science Company Detail
11.11.2 Lubrizol Life Science Business Overview
11.11.3 Lubrizol Life Science Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.11.4 Lubrizol Life Science Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.11.5 Lubrizol Life Science Recent Development
11.12 Recipharm AB
11.12.1 Recipharm AB Company Detail
11.12.2 Recipharm AB Business Overview
11.12.3 Recipharm AB Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.12.4 Recipharm AB Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.12.5 Recipharm AB Recent Development
11.13 Berkshire Sterile Manufacturing
11.13.1 Berkshire Sterile Manufacturing Company Detail
11.13.2 Berkshire Sterile Manufacturing Business Overview
11.13.3 Berkshire Sterile Manufacturing Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.13.4 Berkshire Sterile Manufacturing Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.13.5 Berkshire Sterile Manufacturing Recent Development
11.14 AbbVie
11.14.1 AbbVie Company Detail
11.14.2 AbbVie Business Overview
11.14.3 AbbVie Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.14.4 AbbVie Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.14.5 AbbVie Recent Development
11.15 Zenvision Pharma LLP
11.15.1 Zenvision Pharma LLP Company Detail
11.15.2 Zenvision Pharma LLP Business Overview
11.15.3 Zenvision Pharma LLP Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.15.4 Zenvision Pharma LLP Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.15.5 Zenvision Pharma LLP Recent Development
11.16 Eurofins
11.16.1 Eurofins Company Detail
11.16.2 Eurofins Business Overview
11.16.3 Eurofins Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.16.4 Eurofins Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.16.5 Eurofins Recent Development
11.17 COC Farmaceutici
11.17.1 COC Farmaceutici Company Detail
11.17.2 COC Farmaceutici Business Overview
11.17.3 COC Farmaceutici Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.17.4 COC Farmaceutici Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.17.5 COC Farmaceutici Recent Development
11.18 Leadgene Biomedical,Inc.
11.18.1 Leadgene Biomedical,Inc. Company Detail
11.18.2 Leadgene Biomedical,Inc. Business Overview
11.18.3 Leadgene Biomedical,Inc. Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.18.4 Leadgene Biomedical,Inc. Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.18.5 Leadgene Biomedical,Inc. Recent Development
11.19 Liof Pharma
11.19.1 Liof Pharma Company Detail
11.19.2 Liof Pharma Business Overview
11.19.3 Liof Pharma Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.19.4 Liof Pharma Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.19.5 Liof Pharma Recent Development
11.20 Argonaut Manufacturing Services
11.20.1 Argonaut Manufacturing Services Company Detail
11.20.2 Argonaut Manufacturing Services Business Overview
11.20.3 Argonaut Manufacturing Services Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.20.4 Argonaut Manufacturing Services Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.20.5 Argonaut Manufacturing Services Recent Development
11.21 Societal CDMO
11.21.1 Societal CDMO Company Detail
11.21.2 Societal CDMO Business Overview
11.21.3 Societal CDMO Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.21.4 Societal CDMO Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.21.5 Societal CDMO Recent Development
11.22 PharmTech
11.22.1 PharmTech Company Detail
11.22.2 PharmTech Business Overview
11.22.3 PharmTech Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.22.4 PharmTech Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.22.5 PharmTech Recent Development
11.23 Oakwood Labs
11.23.1 Oakwood Labs Company Detail
11.23.2 Oakwood Labs Business Overview
11.23.3 Oakwood Labs Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.23.4 Oakwood Labs Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.23.5 Oakwood Labs Recent Development
11.24 IDT Biologika
11.24.1 IDT Biologika Company Detail
11.24.2 IDT Biologika Business Overview
11.24.3 IDT Biologika Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.24.4 IDT Biologika Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.24.5 IDT Biologika Recent Development
11.25 EMCM
11.25.1 EMCM Company Detail
11.25.2 EMCM Business Overview
11.25.3 EMCM Lyophilization Contract Manufacturing Services (CDMO) Introduction
11.25.4 EMCM Revenue in Lyophilization Contract Manufacturing Services (CDMO) Business (2019-2024)
11.25.5 EMCM Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Thermo Fisher Scientific Inc.
Ascendia Pharmaceuticals
PCI Pharma Services
Ellab
Lyophilization Technology,Inc.
Lundbeck
LSNE Con鈥嬧�媡ract Manufacturing
Pfizer
Jubilant Pharmova
CARBOGEN AMCIS
Lubrizol Life Science
Recipharm AB
Berkshire Sterile Manufacturing
AbbVie
Zenvision Pharma LLP
Eurofins
COC Farmaceutici
Leadgene Biomedical,Inc.
Liof Pharma
Argonaut Manufacturing Services
Societal CDMO
PharmTech
Oakwood Labs
IDT Biologika
EMCM
听
听
*If Applicable.
